A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults

一项评估透明质酸酶辅助皮下注射20%免疫球蛋白在健康成人中耐受性、安全性和免疫原性的1期开放标签研究